Showing results (31-40 of 324) with videos related to

Sort By:
Pageof 33
Future Oncology (London, England)|August 23, 2021
Brigatinib vs alectinib in crizotinib-resistant advanced anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALTA-3)Sanjay Popat, Geoffrey Liu, Shun Lu, et al.
Expert Opinion on Drug Safety|May 24, 2016
Safety of gefitinib in non-small cell lung cancer treatmentEmily Han-Chung Hsiue, Jih-Hsiang Lee, Chia-Chi Lin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2010
Efficacy and safety of cisplatin/pemetrexed versus cisplatin/gemcitabine as first-line treatment in East Asian patients with advanced non-small cell lung cancer: results of an exploratory subgroup analysis of a phase III trialChih-Hsin Yang, Lorinda Simms, Keunchil Park, et al.
Expert Review of Molecular Diagnostics|October 15, 2016
Profile of the therascreen® EGFR RGQ PCR kit as a companion diagnostic for gefitinib in non-small cell lung cancerEmily Han-Chung Hsiue, Jih-Hsiang Lee, Chia-Chi Lin, et al.
Lung Cancer (Amsterdam, Netherlands)|May 29, 2009
Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancerJenn-Yu Wu, Chong-Jen Yu, Jin-Yuan Shih, et al.
Lung Cancer (Amsterdam, Netherlands)|October 16, 2007
Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancersJo-Pai Chen, Yin Lo, Chong-Jen Yu, et al.
Genes, Chromosomes & Cancer|August 15, 2018
Driver mutations of young lung adenocarcinoma patients with malignant pleural effusionShang-Gin Wu, Yi-Nan Liu, Chong-Jen Yu, et al.
Pageof 33